In addition, the therapeutic efficacy of IL-2 IC plus tacrolimus was observed in MRL/lpr mice, a lupus model (Supplementary Figure S6), indicating that the beneficial effect of IL-2 IC concomitantly used with tacrolimus is not restricted to SLE-like GVHD models. This evidence concerns the gene IL2 and graft versus host disease.